Atsushi Hasuoka
Fujisawa, 2518555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate.
Journal: Bioorganic & medicinal chemistry
Published: February 20, 2017
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: February 14, 2017
Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs).
Journal: Bioorganic & medicinal chemistry letters
Published: November 11, 2014
Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers.
Journal: Chemical & pharmaceutical bulletin
Published: April 04, 2014
Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists.
Journal: Bioorganic & medicinal chemistry
Published: September 26, 2012
Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
Journal: Journal of medicinal chemistry
Published: April 20, 2012
Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
Journal: Bioorganic & medicinal chemistry
Published: February 23, 2012
Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists.
Journal: Bioorganic & medicinal chemistry
Published: January 09, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026